317 related articles for article (PubMed ID: 21894658)
1. International Conference on Harmonisation; Guidance on E2F Development Safety Update Report; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2011 Aug; 76(163):52667-8. PubMed ID: 21894658
[TBL] [Abstract][Full Text] [Related]
2. International Conference on Harmonisation; draft guidance on E2F Development Safety Update Report; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2008 Aug; 73(151):45462-3. PubMed ID: 18949880
[TBL] [Abstract][Full Text] [Related]
3. International Conference on Harmonisation; guidance on Addendum to E2C Clinical Safety Data Management: Periodic Safety Update Reports for Marketed Drugs; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(24):5551-2. PubMed ID: 14968802
[TBL] [Abstract][Full Text] [Related]
4. International Conference on Harmonisation; Guidance on Q8 Pharmaceutical Development; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2006 May; 71(98):29344-5. PubMed ID: 16749216
[TBL] [Abstract][Full Text] [Related]
5. International Conference on Harmonisation; Guidance on E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure, and Format of Qualification Submissions; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2011 Aug; 76(155):49773-4. PubMed ID: 21834216
[TBL] [Abstract][Full Text] [Related]
6. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Oct; 66(200):52634-7. PubMed ID: 12358037
[TBL] [Abstract][Full Text] [Related]
7. International Conference on Harmonisation; Guidance on S9 Nonclincal Evaluation for Anticancer Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Mar; 75(44):10487-8. PubMed ID: 20383918
[TBL] [Abstract][Full Text] [Related]
8. International Conference on Harmonisation; guidance on data elements for transmission of individual case safety reports; availability. Notice. Food and Drug Administration, HHS.
Fed Regist; 1998 Jan; 63(10):2396-404. PubMed ID: 12296373
[TBL] [Abstract][Full Text] [Related]
9. International Conference on Harmonisation; Guidance on E7 Studies in Support of Special Populations; Geriatrics; Questions and Answers; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2012 Feb; 77(34):9948-9. PubMed ID: 22379685
[TBL] [Abstract][Full Text] [Related]
10. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097
[TBL] [Abstract][Full Text] [Related]
11. International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2012 May; 77(97):29665-6. PubMed ID: 22616137
[TBL] [Abstract][Full Text] [Related]
12. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2008 Feb; 73(35):9575-6. PubMed ID: 18677819
[TBL] [Abstract][Full Text] [Related]
13. International Conference on Harmonisation: guidance on Q1D bracketing and matrixing designs for stability testing of new drug substances and products; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Jan; 68(11):2339-40. PubMed ID: 12532979
[TBL] [Abstract][Full Text] [Related]
14. International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Feb; 68(28):6924-5. PubMed ID: 12583358
[TBL] [Abstract][Full Text] [Related]
15. International Conference on Harmonisation; guidance on electronic common technical document specification; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Apr; 68(63):16060-1. PubMed ID: 12674113
[TBL] [Abstract][Full Text] [Related]
16. International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Nov; 68(220):64628-9. PubMed ID: 14619944
[TBL] [Abstract][Full Text] [Related]
17. International Conference on Harmonisation; Guidance on Q11 Development and Manufacture of Drug Substances; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2012 Nov; 77(224):69634-5. PubMed ID: 23227566
[TBL] [Abstract][Full Text] [Related]
18. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial texts for use in the International Conference on Harmonisation Regions; Annex 12 on Analytical Sieving General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Sep; 75(170):53873-4. PubMed ID: 20812423
[TBL] [Abstract][Full Text] [Related]
19. International Conference on Harmonisation; guidance on good manufacturing practice for active pharmaceutical ingredients; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Sep; 66(186):49028-9. PubMed ID: 12358036
[TBL] [Abstract][Full Text] [Related]
20. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; Annex 5 on Disintegration Test General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Dec; 74(245):68270-1. PubMed ID: 20344862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]